Active Ingredient: NILOTINIB
Proprietary Name: CAVHANZA
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 80MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217379
Product Number: 002
Approval Date: May 29, 2026
Applicant Holder Full Name: FLEX PHARMA LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
